Mounting evidence has demonstrated that the molecular characteristics of gliomas include mutated isocitrate dehydrogenase 1 and 2 genes (IDH1/2) and co-deletion of 1p/19q (Aldape et al., 2019). This evidence concerns the gene IDH1 and central nervous system cancer.